Laboratory Corporation of America Holdings (LH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Laboratory Corporation of America Holdings (LH) has a cash flow conversion efficiency ratio of 0.022x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($191.50 Million) by net assets ($8.75 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see LH market cap for the company's overall valuation and market capitalisation.
Laboratory Corporation of America Holdings - Cash Flow Conversion Efficiency Trend (1989–2025)
This chart illustrates how Laboratory Corporation of America Holdings's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Laboratory Corporation of America Holdings Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Laboratory Corporation of America Holdings ranked by their cash flow conversion efficiency. Explore Laboratory Corporation of America Holdin (LH) cash flow quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Schindler Holding AG
SW:SCHN
|
0.116x |
|
S.F. Holding Co. Ltd
SHE:002352
|
0.061x |
|
SK Holdings Co Ltd
KO:034730
|
0.034x |
|
Credicorp Ltd
F:D8V
|
-0.019x |
|
NRG Energy Inc.
NYSE:NRG
|
-0.035x |
|
Centrais Elétricas Brasileiras S.A. - Eletrobrás
SA:AXIA3
|
0.040x |
|
Loews Corp
NYSE:L
|
0.048x |
|
Liberty Media Corporation Series C Liberty Formula One Common Stock
NASDAQ:FWONK
|
0.042x |
Annual Cash Flow Conversion Efficiency for Laboratory Corporation of America Holdings (1989–2025)
The table below shows the annual cash flow conversion efficiency of Laboratory Corporation of America Holdings from 1989 to 2025. View Laboratory Corporation of America Holdin share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $8.64 Billion | $1.64 Billion | 0.190x | -3.38% |
| 2024-12-31 | $8.07 Billion | $1.59 Billion | 0.197x | +16.83% |
| 2023-12-31 | $7.89 Billion | $1.33 Billion | 0.168x | -12.98% |
| 2022-12-31 | $10.12 Billion | $1.96 Billion | 0.193x | -35.99% |
| 2021-12-31 | $10.29 Billion | $3.11 Billion | 0.302x | +33.79% |
| 2020-12-31 | $9.46 Billion | $2.14 Billion | 0.226x | +18.18% |
| 2019-12-31 | $7.56 Billion | $1.44 Billion | 0.191x | +2.31% |
| 2018-12-31 | $6.99 Billion | $1.31 Billion | 0.187x | -14.01% |
| 2017-12-31 | $6.72 Billion | $1.46 Billion | 0.217x | +1.97% |
| 2016-12-31 | $5.52 Billion | $1.18 Billion | 0.213x | +11.47% |
| 2015-12-31 | $5.14 Billion | $982.40 Million | 0.191x | -26.62% |
| 2014-12-31 | $2.84 Billion | $739.00 Million | 0.260x | -21.09% |
| 2013-12-31 | $2.48 Billion | $818.70 Million | 0.330x | +7.95% |
| 2012-12-31 | $2.75 Billion | $841.40 Million | 0.306x | -9.84% |
| 2011-12-31 | $2.52 Billion | $855.60 Million | 0.339x | +1.10% |
| 2010-12-31 | $2.63 Billion | $883.60 Million | 0.335x | -12.57% |
| 2009-12-31 | $2.25 Billion | $862.40 Million | 0.384x | -11.12% |
| 2008-12-31 | $1.81 Billion | $780.90 Million | 0.432x | +4.91% |
| 2007-12-31 | $1.73 Billion | $709.70 Million | 0.411x | +28.62% |
| 2006-12-31 | $1.98 Billion | $632.30 Million | 0.320x | +5.03% |
| 2005-12-31 | $1.89 Billion | $574.20 Million | 0.305x | +11.71% |
| 2004-12-31 | $1.97 Billion | $538.10 Million | 0.273x | -8.42% |
| 2003-12-31 | $1.90 Billion | $564.30 Million | 0.298x | +9.92% |
| 2002-12-31 | $1.64 Billion | $444.90 Million | 0.271x | -7.00% |
| 2001-12-31 | $1.09 Billion | $316.00 Million | 0.291x | +3.54% |
| 2000-12-31 | $877.40 Million | $246.70 Million | 0.281x | +14.37% |
| 1999-12-31 | $734.20 Million | $180.50 Million | 0.246x | +33.87% |
| 1998-12-31 | $681.20 Million | $125.10 Million | 0.184x | -19.88% |
| 1997-12-31 | $630.00 Million | $144.40 Million | 0.229x | +131.67% |
| 1996-12-31 | $258.10 Million | $-186.80 Million | -0.724x | -733.82% |
| 1995-12-31 | $411.60 Million | $47.00 Million | 0.114x | +28.95% |
| 1994-12-31 | $166.00 Million | $14.70 Million | 0.089x | -78.20% |
| 1993-12-31 | $140.80 Million | $57.20 Million | 0.406x | -14.36% |
| 1992-12-31 | $212.50 Million | $100.80 Million | 0.474x | +17.10% |
| 1991-12-31 | $330.80 Million | $134.00 Million | 0.405x | -7.49% |
| 1990-12-31 | $256.70 Million | $112.40 Million | 0.438x | +101.25% |
| 1989-12-31 | $330.00 Million | $71.80 Million | 0.218x | -- |
About Laboratory Corporation of America Holdings
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcoh… Read more